The Company was incorporated on 2 May 2001 as a private company limited. The
Company converted into a public company on 16 June 2011 in connection with the
distribution in specie of all of our Shares to the shareholders of CBB,
undertaken by CBB, in its capacity as sole shareholder of our Company, on 30
June 2011. In relation thereto, the Company changed its name to “Cordlife Group
Limited”. The Group currently comprises its Company and its subsidiaries,
namely, CLS Services Pte Ltd (“CLS Services”), Cordlife (Hong Kong) Limited
(“Cordlife Hong Kong”) and Shanghai Cordlife Biomedical Research Co Ltd
(“Cordlife Shanghai”).
The Group is amongst the first private cord blood banks in Asia. Its business
is focused on providing Cord Blood Banking Services which include the
collection, processing, testing, cryopreservation and storage of umbilical cord
blood at birth. In March 2011, we also launched the provision of umbilical cord
tissue banking services in Hong Kong, which comprise the collection,
processing, testing, cryopreservation and storage of the umbilical cord
itself. The Group currently provides Cord Blood Banking Services in Singapore
and Hong Kong. The Group also provides Cord Blood Banking Services to
customers from Indonesia, Macau and the Philippines.
SGX source · Source update: 07/17/2026 08:45:30 AM (timezone not specified). Source text may be historical.